Cat. No. | Product name | CAS No. |
DC21751 |
TiY
TiY (TIC Fluorescent Probe TiY) is the first TIC (tumor initiating cell)-specific fluorescent chemical probe, target vimentin, a marker for epithelial-to-mesenchymal transition (EMT). |
|
DC21752 |
TJ191
TJ191 is a selective anti-cancer small molecule that targets low TβRIII-expressing malignant T-cell leukemia/lymphoma cells (MOLT-3 IC50=0.26 uM). |
1522415-97-9 |
DC21753 |
TK216
TK216 is a first in class, small molecule that directly binds EWS-FLI1 inhibiting the biological activity of ETS-family transcription factor oncoproteins and is currently under clinical investigation against Ewing sarcoma.. |
|
DC23620 |
TKDC
TKDC is a small molecule allosteric inhibitor of TREK channels with IC50 of 4.9, 5.2 and 65.9 uM for TREK-1, TREK-2 and TRAAK, respectively. |
425666-42-8 |
DC22247 |
TL02-59
TL02-59 is a potent, selective, orally available inhibitor of Src-family kinase Fgr IC50 of 0.03 nM, also inhibits Lyn and Hck with IC50 of 0.1 and 160 nM, respectively. |
1315330-17-6 |
DC21961 |
TL13-112
TL13-112 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of LDK378 and the cereblon ligand pomalidomide. |
2229037-19-6 |
DC21962 |
TL13-12
Featured
TL13-12 is a novel Anaplastic Lymphoma Kinase (ALK)-PROTAC developed through conjugation of TAE684 and the cereblon ligand pomalidomide. |
2229037-04-9 |
DC10963 |
TLR7 and 8 modulator 31
TLR7 and 8 modulator 31 is a potent, orally active, dual TLR7 and 8 agonist with LEC values of 0.15 and 0.16 uM, respectively. |
1413944-59-8 |
DC21754 |
TLSC702
TLSC702 is a novel potent inhibitor of human glyoxalase I (hGLO I) with IC50 of 2.0 uM. |
748786-57-4 |
DC20099 |
TM-25659
TM-25659 is a TAZ modulator. Anti-osteoporotic and anti-obesity activities. |
260553-97-7 |
DC7328 |
TM30089
TM30089 is a slective CRTH2 antagonist, displaying high antagonistic potency on mouse CRTH2 with low affinity to TP and many other prostanoid receptors including the related anaphylatoxin C3a and C5a receptors. |
844639-57-2 |
DC22248 |
TM5007
Featured
TM5007 is a poent inhibitor plasminogen activator inhibitor-1 (PAI-1) with IC50 of 29 uM, exhibits no inhibitory activity against any of the closely related serpins or serine proteases at 250 uM. . |
342595-05-5 |
DC9618 |
TMC353121
TMC353121 is a potent RSV fusion inhibitor with pEC50 of 9.9(t1/2 in lung = 25 h). |
857066-90-1 |
DC7872 |
TMC647055
TMC647055 is a novel and potent nonnucleoside inhibitor of the HCV NS5B RNA-dependent RNA polymerase. |
1204416-97-6 |
DC21755 |
TMP-153
TMP-153 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor with IC50 of 5-10 nM for the hepatic and intestinal ACAT from various animals. |
128831-46-9 |
DC11846 |
TMP778
Featured
TMP778 (TMP-778) is a potent, selective RORγt inhibitor with IC50 of 7 nM in FRET assays and 63 nM in IL-17 promoter assays, with no inverse agonist activity. |
1422171-08-1 |
DC20569 |
TMPyP4 tosylate
TMPyP4 tosylate is a potent inhibitor of human telomerase with IC50 of 6.5 uM. |
36951-72-1 |
DC21963 |
TNIK inhibitor X
TNIK inhibitor X is a potent inhibitor of Traf2- and Nck-interacting kinase (TNIK) (in vitro enzyme IC50=9 nM) with a reasonable selectivity over 30-folds against the majority of a panel of 50 kinases profiled. |
933886-36-3 |
DC21757 |
TNP-351
TNP-351 is an antifolate compound that functions as a DHFR inhibitor, strongly inhibits the growth of Meth A cells.. |
125991-51-7 |
DC21758 |
TNP-470
TNP-470 (AGM-1470) is a specific, rreversible MetAP-2 inhibitor and and annti-angiogenic compound, inhibits endothelial cell proliferation and angiogenesis. |
129298-91-5 |
DC10381 |
TOFA
TOFA (RMI14514;MDL14514) is an allosteric inhibitor of acetyl-CoA carboxylase-α (ACCA ). |
54857-86-2 |
DC20922 |
Tofimilast
Tofimilast (CP-325366) is a potent, selective PDE4 inhibitor with IC50 of 23, 13 and 13 nM for PDE4A, PDE4B, and PDE4D, respectively. |
185954-27-2 |